Adtalem Global Education Inc.

Adtalem Global Education Inc. (ATGE) Market Cap

Adtalem Global Education Inc. has a market capitalization of $3.87B.

Price: $106.64

1.57 (1.49%)

Market Cap: 3.87B

NYSE · time unavailable

CEO: Stephen W. Beard

Sector: Consumer Defensive

Industry: Education & Training Services

IPO Date: 1991-06-21

Website: https://www.adtalem.com

Adtalem Global Education Inc. (ATGE) - Company Information

Market Cap: 3.87B|Sector: Consumer Defensive

Company Profile

Adtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.

Analyst Sentiment

92%
Strong Buy

From 3 Active Polls

1Y Forecast: $138.00

▲ +29.4% Potential Upside

Consensus Target Metrics

Low Bound

$138

Median

$138

High Bound

$138

Average

$138

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$138.00
▲ +29.41% Upside
Low Target
$138.00
29% Risk
Median Target
$138.00
29% Mid
High Target
$138.00
29% Max
Consensus
Buy
3 / 3 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)3,8743,9513,7635,7884,7623,8503,4012,9532,526
Enterprise Value ($M)4,8874,5394,4366,2995,3374,4124,0723,5323,155
Price to Earnings Ratio (P/E)18.5023.7212.3223.4021.9615.8211.2115.9912.78
Price/Earnings-to-Growth Ratio (PEG)1.3920.643.871.548.75
Price to Sales Ratio (P/S)2.258.117.4812.5210.428.267.607.076.16
Price to Book Ratio (P/B)3.172.902.733.973.322.692.362.121.85
Price to Free Cash Flow Ratio (P/FCF)12.7823.81248.8950.54117.0019.48-114.5137.4357.82
Enterprise Value to Sales (EV/Sales)9.328.8113.6311.689.479.098.467.70
Enterprise Value to EBITDA (EV/EBITDA)11.3340.1734.4163.7058.9339.9134.2841.5835.09
Debt to Equity Ratio1.360.540.530.530.540.540.600.610.62

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 ADTALEM GLOBAL EDUCATION INC (ATGE) — Investment Overview

🧩 Business Model Overview

Adtalem Global Education operates post-secondary education programs delivered through a portfolio of university and professional education brands, with a meaningful emphasis on healthcare and career-focused credentials (including nursing and allied health, as well as medical education and exam-oriented pathways). The business creates value by converting students into enrolled “program participants” and then managing the operational process required to keep them progressing through structured curricula, assessment milestones, and (where relevant) clinical rotations or licensure-prep components.

The model is characterized by an enrollment-to-completion workflow: recruitment and onboarding drive student starts; ongoing term progression produces tuition revenue; and completion/credentialing influences retention, outcomes, and eligibility under regulatory frameworks. Because many programs require uninterrupted participation to reach licensure outcomes, student progress drives customer stickiness and continuity of cash flows.

💰 Revenue Streams & Monetisation Model

Revenue is primarily tuition-based, generated from students who enroll in degree and non-degree programs across terms (typically online and in-person components depending on the program). Monetisation is largely transactional per term (tuition per enrolled student), but with a “cohort continuity” dynamic: students generally remain monetizable across multiple terms until completion, creating a semi-recurring earnings profile tied to retention and course progression.

Margin drivers are operational and program-mix dependent:

  • Enrollment scale and capacity utilization: higher student throughput can leverage fixed instructional and administrative costs.
  • Program mix: healthcare and professional pathways often support pricing power relative to broader academic offerings, but require investment in compliance and student services.
  • Student services efficiency: advising, outcomes support, and retention initiatives affect net revenue through persistence and reduced attrition.
  • Regulatory and aid eligibility effects: federal student aid rules influence effective demand and revenue recognition dynamics.

🧠 Competitive Advantages & Market Positioning

ATGE’s competitive position is anchored in moats that are difficult to replicate quickly due to regulatory accreditation requirements, licensure-linked outcomes, and operational capabilities.

  • Regulatory moat (accreditation & program approval barriers): Educational providers must satisfy accreditation standards and maintain eligibility for student aid. Developing compliant programs, hiring credentialed faculty, and meeting oversight requirements creates a high barrier to entry for new entrants and limits “fast-follow” competitive disruption.
  • Switching costs via credential progression: Students typically commit to structured pathways with accumulated credits and progress toward licensure or professional credentialing. Changing providers can forfeit credits, delay completion, or create licensure disadvantages, increasing stickiness within a completed program track.
  • Intangible assets in outcomes and student support: Outcomes performance, advising, and remediation play a disproportionate role in student persistence and institutional compliance. These capabilities are built over time and are difficult to copy without comparable systems and experience.

Competitive benchmarking (industry focus vs peers):

  • Strategic Education (SE) — diversified higher-education offerings with strong online presence (e.g., Capella). ATGE’s emphasis is comparatively more concentrated in healthcare-anchored education and licensure-connected pathways.
  • Grand Canyon Education (GCE) — large-scale education provider with a substantial footprint in teaching and related fields. GCE competes for overlapping online demand pools, while ATGE’s healthcare-centric positioning differentiates program needs and outcome expectations.
  • Kaplan (Graham Holdings) — broad education and test-prep footprint. Kaplan competes strongly on flexibility and program breadth, but ATGE’s regulatory program structure and credential completion model create different switching dynamics for students pursuing licensure-linked healthcare credentials.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is driven less by product “refresh cycles” and more by structural workforce needs and credential demand:

  • Healthcare workforce expansion: persistent demand for nurses, allied health professionals, and medical education capacity increases the addressable market for credential-based providers.
  • Online and hybrid learning penetration: broader acceptance of remote education supports continued student acquisition at scale, while improving geographic accessibility.
  • Credentialing requirements and career mobility: employers and regulatory bodies increasingly align hiring and advancement to recognized credentials, supporting student willingness to progress through established programs.
  • Capacity and program optimization: improving retention, reducing time-to-completion where feasible, and managing instructional utilization can compound over multiple cohorts.

⚠ Risk Factors to Monitor

  • Federal and regulatory risk: Higher-education regulation and changes to student aid eligibility can alter demand, enrollment quality, and revenue durability.
  • Accreditation and outcomes compliance: Failure to meet accreditation standards or outcomes-based oversight can constrain growth, change program structures, or lead to corrective actions.
  • Clinical placement and capacity constraints: Healthcare programs can face bottlenecks in clinical site availability and associated costs, affecting throughput and persistence.
  • Enrollment cycle volatility: Education demand can react to macro conditions, student financing availability, and competitive recruiting intensity.
  • Legal and reputational overhang: Like peers in the sector, institutions are exposed to litigation risk and reputational scrutiny that can influence enrollments and compliance cost.

📊 Valuation & Market View

Equity research coverage for education providers typically frames valuation around operating leverage and regulatory risk rather than near-term “growth optics.” Market participants often monitor:

  • Profitability and cash generation: enterprise value relative to operating earnings and free cash flow capacity tends to guide valuation, especially where earnings quality is supported by stable retention and cohort persistence.
  • Enrollment and persistence metrics: the market generally rewards durability of student progression and demand quality, which affects both revenue and compliance outcomes.
  • Regulatory risk premium: changes to federal aid, accreditation standards, or outcomes-based rules can expand or contract multiples by changing perceived earnings stability.

In practice, sector valuation typically trends with EV/EBITDA or P/S (as investors price growth and the risk-adjusted durability of tuition receipts), with key variable drivers being enrollment stability, margin trajectory, and regulatory visibility.

🔍 Investment Takeaway

ATGE presents a long-term thesis grounded in healthcare-tilted credential demand, supported by moats formed through regulatory accreditation barriers, student switching costs tied to program progression, and operational know-how in outcomes-focused student support. The investment case depends on maintaining compliance strength and enrollment persistence while navigating regulatory and capacity risks inherent to post-secondary education.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for ATGE.

defenseworld.net2026-03-15

Algert Global LLC Cuts Stock Position in Adtalem Global Education Inc. $ATGE

Algert Global LLC trimmed its holdings in shares of Adtalem Global Education Inc. (NYSE: ATGE) by 16.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 147,065 shares of the company's stock after selling 27,962 shares during the

defenseworld.net2026-03-12

CreativeOne Wealth LLC Invests $862,000 in Adtalem Global Education Inc. $ATGE

CreativeOne Wealth LLC bought a new stake in Adtalem Global Education Inc. (NYSE: ATGE) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,584 shares of the company's stock, valued at approximately $862,000. Other large investors have also recently made changes

defenseworld.net2026-03-08

Adtalem Global Education Inc. $ATGE Position Reduced by Citigroup Inc.

Citigroup Inc. trimmed its position in Adtalem Global Education Inc. (NYSE: ATGE) by 56.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,320 shares of the company's stock after selling 19,894 shares during the quarter. Citigroup

businesswire.com2026-02-24

Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day

CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: ATGE), today will host its Investor Day beginning at 9 a.m. ET. Covista is America's largest healthcare educator, serving more than 97,000 students, up from nearly 76,000 students since its last Investor Day in June 2023, and supported by a community of 385,000 alumni across five accredited institutions. Effective at market open, the company's stock will begin trading under the ticker symbol CVSA on the New York Stock Exchang.

businesswire.com2026-02-17

Ross University School of Medicine Welcomes New Dean

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: ATGE), America's largest healthcare educator, today announced Cheryl Holmes, M.D., a fellow of the Royal College of Physicians of Canada with a master's degree in health professions education, as the next dean of Ross University School of Medicine (RUSM) effective March 16. “I am thrilled to welcome Dr. Holmes, and confident that her impressive experience spanning clinical practice, research and academic leadership will be invaluable to our students, fac.

zacks.com2026-02-16

Why Adtalem Global Education (ATGE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

fool.com2026-02-13

Why This $14 Million Bet on Adtalem Global Stock Could Signal a Healthcare Education Pivot

First Sabrepoint Capital Management initiated a new 135,000-share stake in Adtalem Global Education during the fourth quarter. The quarter-end position value increased by $13.97 million due to the initiation of the new position.

gurufocus.com2026-02-13

John Rogers' Strategic Moves: Sphere Entertainment Co Sees Significant Reduction

Exploring the Fourth Quarter 2025 13F Filing John Rogers (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insigh

zacks.com2026-02-13

Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround

Adtalem (ATGE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

zacks.com2026-02-10

ATGE or LOPE: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Schools sector might want to consider either Adtalem Global Education (ATGE) or Grand Canyon Education (LOPE). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-02-09

ATGE vs. LOPE: Which Stock Is the Better Value Option?

Investors with an interest in Schools stocks have likely encountered both Adtalem Global Education (ATGE) and Grand Canyon Education (LOPE). But which of these two stocks presents investors with the better value opportunity right now?

defenseworld.net2026-02-07

Federated Hermes Inc. Buys 5,184 Shares of Adtalem Global Education Inc. $ATGE

Federated Hermes Inc. boosted its stake in Adtalem Global Education Inc. (NYSE: ATGE) by 510.2% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,200 shares of the company's stock after purchasing an additional 5,184 shares during the quarter.

defenseworld.net2026-02-07

Renaissance Group LLC Buys Shares of 59,279 Adtalem Global Education Inc. $ATGE

Renaissance Group LLC purchased a new position in shares of Adtalem Global Education Inc. (NYSE: ATGE) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 59,279 shares of the company's stock, valued at approximately $9,156,000. Renaissance Group LLC owned approximately 0.16% of Adtalem

defenseworld.net2026-02-07

Adtalem Global Education Inc. $ATGE Stake Lifted by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans raised its stake in Adtalem Global Education Inc. (NYSE: ATGE) by 29.0% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 34,073 shares of the company's stock after buying an additional 7,655 shares during the quarter. Thrivent Financial for Lutherans owned approximately

zacks.com2026-02-06

Adtalem Rebrands as Covista With Focus on Healthcare Workforce Needs

Covista emerges from ATGE's healthcare-focused overhaul, positioning itself as workforce infrastructure aimed at easing America's medical staffing shortage.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"ATGE (2026-03-31) reported Revenue of $487.0M and Net Income of $42.6M, with EPS of $1.19 (basic) and $1.67 (diluted). QoQ, Revenue declined from $503.4M (2025-12-31) to $487.0M (down ~3.3%), while Net Income also fell from $76.4M to $42.6M (down ~44.2%). YoY, Revenue increased from $466.1M (2025-03-31) to $487.0M (up ~4.5%), and Net Income rose from $60.8M to $42.6M (down ~30.0%), indicating profit pressure despite modest top-line growth. Profitability contracted over the 4-quarter period: gross margin was negative in the most recent quarter (-114.9% gross margin ratio) versus positive ~56–59% in prior quarters, while operating income remained positive at $91.3M but operating margin fell to ~18.8% from ~22.1% in Q2 (and ~19.5% in Q3 prior year). Cash flow quality remained strong: operating cash flow was $186.1M and free cash flow $165.9M in Q3, despite lower net income. Balance sheet leverage increased: total assets rose to ~$2.74B, equity was stable near ~$1.36B, and net debt increased to ~$589M from ~$673M (improved), though total debt remains elevated. Shareholder returns: dividends were $0. The company repurchased stock (common stock repurchased $67.5M), supporting total return, but marketPerformance data (1y_change) is unavailable, so valuation/price-momentum impact could not be scored."

Revenue Growth

Neutral

QoQ revenue decreased ~3.3% (503.4M to 487.0M) but YoY revenue increased ~4.5% (466.1M to 487.0M).

Profitability

Neutral

Net income fell ~44.2% QoQ and ~30.0% YoY. Operating margin declined to ~18.8% from ~22.1% (Q2). Gross profit ratio turned sharply negative in the latest quarter (-114.9%), signaling severe gross-level pressure or classification volatility.

Cash Flow Quality

Positive

Operating cash flow improved to $186.1M and free cash flow was $165.9M in the latest quarter, indicating solid cash conversion despite lower reported net income.

Leverage & Balance Sheet

Fair

Total assets increased to ~$2.74B. Equity remains stable around ~$1.36B. Net debt improved to ~$589M from ~$673M QoQ, though total debt remains substantial (~$736M).

Shareholder Returns

Fair

No dividends. Buybacks continued (repurchased ~$67.5M in the latest quarter), supporting capital return, but total shareholder return cannot be fully quantified due to missing marketPerformance (1y_change undefined).

Analyst Sentiment & Valuation

Caution

Valuation sentiment is hard to gauge: current price is not provided (marketPerformance shows price=0 and 1y_change undefined). Provided consensus price target is $138, but upside/downside vs current share price cannot be calculated from the dataset.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

ATGE reported Q3’26 revenue of $487M (+4.5% YoY), but management highlighted that a Walden 1-week academic calendar shift moved $18M of revenue and distorted margin optics. On an “ex timing” basis, consolidated revenue growth was +8.4% and adjusted EBITDA margin rose +150 bps to 28.9% (adjusted EBITDA $145.9M). Segment performance was strongest in Walden (enrollment +12.3%, adjusted EBITDA margin +280 bps to 33.1%) and med/vet (margin +250 bps to 26.5%). Chamberlain returned to positive enrollment growth (+0.5%) after prior-cycle execution issues; KPIs improved and conversion normalized toward historical rates, supporting raised guidance. Full-year revenue guidance increased to $1.93B–$1.945B and adjusted EPS to $7.95–$8.15 (+19% to +22% YoY). Capital allocation remained shareholder-friendly: $66M buyback, 50 bps debt-rate improvement via refinancing, and net leverage of 0.7x. Risks primarily center on sustaining conversion execution through the September cycle and higher tax rate.

AI IconGrowth Catalysts

  • Enrollment growth across all 3 segments: total enrollment up 6.8% in the quarter; Walden +12.3% (record) and Chamberlain +0.5% (returned to positive growth)
  • Chamberlain operational remediation driving funnel improvement: localized marketing, simplified application, rebuilt scholarship process, upgraded enrollment talent; applications up and conversion normalized vs historical
  • Walden persistence compounding: continued retention discipline supporting +280 bps EBITDA margin despite operating calendar timing
  • Medical & Veterinary operating leverage: revenue +8.9% and adjusted EBITDA margin +250 bps to 26.5%
  • AI credential and AI education platform momentum: 4,000+ learners enrolled in newly launched AI credentials; AI classroom pilots launching later in 2026

Business Development

  • SSM partnership: relationship “continues to thrive,” with increased applications/inquiries around the St. Louis campus; management declined specifics but called it a key proof point and expected additional employer partnership announcements “in the near term”
  • Google Cloud enterprise work: codeveloping an AI-powered classroom within the platform; AI credentials demand and additional certificate launches later in 2026
  • Employer partnership pipeline: “several conversations active around the country” with care providers; no additional named partners disclosed

AI IconFinancial Highlights

  • Revenue: $487.0M (+4.5% YoY); excluding the Walden 1-week timing shift revenue would have risen to +8.4% YoY (Walden timing moved $18M from Q3 into Q2)
  • Adjusted EPS: $1.98 (impacted by Walden calendar shift); raised full-year adjusted EPS guidance to $7.95–$8.15 from $7.80–$8.00
  • Adjusted EBITDA: $127.9M; excluding timing, adjusted EBITDA would have increased +14.2% to $145.9M
  • Adjusted EBITDA margin: 28.9% excluding timing, up +150 bps YoY
  • Adjusted EBITDA margin by segment: Chamberlain +20 bps to 29.7%; Walden +280 bps to 33.1% (excluding timing); med/vet +250 bps to 26.5%
  • Adjusted operating income: $102.2M; excluding timing, +14.1% YoY to $120.3M
  • Free cash flow: trailing 12-month free cash flow +17% to $336M
  • Balance sheet/macro-related note: management referenced an “elevated level” of targeted strategic growth investments in Q4 and higher effective tax rate vs FY2025, but provided no specific tax bps or tariff values

AI IconCapital Funding

  • Share repurchases: $66M during the quarter
  • Debt/interest rate: refinanced long-term debt; Term Loan B $510M with 50 bps rate improvement and extended maturity to 2033
  • Leverage: net leverage 0.7x at March 31, 2026
  • Cash: $147M cash and equivalents at quarter end
  • Cash runway: management indicated multiple capital-allocation paths enabled by cash generation (campus expansion, employer partnerships, AI platform, and opportunistic shareholder returns)

AI IconStrategy & Ops

  • Chamberlain: post-fall-cycle anomaly remediation showing in KPIs and reported enrollment—application volumes improved sharply and funnel conversion increased; new President start in earnest next week (Amelia Manning)
  • Enrollment model guidance: Q4 expected to “look like Q3 with momentum building into the fall enrollment cycle”; later clarified as growth rate directionally similar (not necessarily absolute enrollment equal)
  • Walden operations: process/workflow automation cut application review time by weeks to improve applicant experience and selection probability
  • Campus expansion execution: six new campuses in active development; first begins teaching in September; two received full regulatory approval since Investor Day
  • CapEx ramp: Q3 CapEx $20M; management expects Q4 CapEx ramp up further vs Q3; and for next year, “good proxy” is ramping by quarter (no single run-rate number provided)
  • Leadership: Michael Betz expanded role (Chief Growth and Innovation Officer) with marketing oversight over Walden and digital

AI IconMarket Outlook

  • Full-year revenue guidance raised to $1.93B–$1.945B from $1.9B–$1.94B (implied +8% to +9% YoY)
  • Full-year adjusted EPS guidance raised to $7.95–$8.15 from $7.80–$8.00 (implied +19% to +22% YoY)
  • Q4 Chamberlain expectation: enrollment growth should be directionally similar to Q3 (management avoided absolute enrollment number parity)
  • Updated margin trajectory: management reiterated commitment to expand fiscal 2026 adjusted EBITDA margin by +100 bps

AI IconRisks & Headwinds

  • Walden 1-week academic calendar shift materially impacted Q3 revenue and margin optics (timing rather than underlying demand), which can obscure comparability
  • Tax rate risk: management expects an effective tax rate higher than FY2025, which can pressure earnings despite revenue/EPS growth
  • Execution risk remains tied to Chamberlain conversion/marketing effectiveness; management’s confidence is based on remediation progress but still requires sustained execution through the September fall cycle
  • Ongoing investment load: management cited elevated targeted strategic growth investments in Q4 that can affect near-term profitability if returns lag

Q&A: Analyst Interest

  • SSM and employer partnership pipeline: Management said SSM “continues to thrive” with increased applications/inquiries around the St. Louis campus, calling it a proof point for new talent-acquisition thinking. They declined specifics, emphasized multiple active care-provider conversations nationwide, and expect announcements “in the near term.”
  • Chamberlain enrollment drivers and RN to BSN demand: Management attributed the return to positive total enrollment to execution remediation (marketing effectiveness and funnel conversion) and reaffirmed a focus on post-licensure nursing trends. They said MSN is larger than RN to BSN but called RN to BSN critical, reporting momentum and conversion normalization toward historical levels.
  • CapEx and investment timing into Q4: Management denied expense shifting from Q3 to Q4, saying a dynamic resource-allocation model enables incremental Q4 investment rather than reclassification. For modeling, CFO cited CapEx ramp by quarter this year and expected further Q4 ramp, with next-year level as a proxy.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the ATGE Q3 2026 (reported 2026-05-08) earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for ATGE.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (ATGE)

© 2026 Stock Market Info — Adtalem Global Education Inc. (ATGE) Financial Profile